Bioharvest Sciences Inc. key statistics and ratios

In fiscal 2025, Bioharvest Sciences Inc. had return on equity of -83.2%, an operating margin of -16.2%, debt equal to 0.6% of equity and a current ratio of 3.97. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bioharvest Sciences Inc.: financial ratios, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Gross margin	44.5%	55.4%	59.3%
Operating margin	−78.6%	−27.7%	−16.2%
Net margin	−99.1%	−51.3%	−32.3%
Free-cash-flow margin	−78.9%	−37.8%	−27.8%
Return on equity	—	—	−83.2%
Current ratio	0.34	0.55	3.97
Debt to equity	—	293.6%	0.6%
Capital spending as % of revenue	11.6%	11.3%	6.8%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: BHST vs VYGR BHST vs CCCC BHST vs FHTX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Bioharvest Sciences Inc.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Bioharvest Sciences Inc.